Anti-citrullinated peptide antibodies a bad sign for RA patients in remission

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Anti-citrullinated peptide antibodies (ACPA) predict clinically relevant radiographic progression (CRRP) at 1 y in patients with rheumatoid arthritis (RA) with low disease activity (LDA) at baseline.

Why this matters

  • This group previously reported on CRRP prognostic marker...